Chau Q. Khuong - May 26, 2021 Form 4 Insider Report for Galecto, Inc. (GLTO)

Role: Director
Signature: /s/ Jonathan Freve, attorney-in-fact
Stock symbol: GLTO
Transactions as of: May 26, 2021
Transactions value $: $0
Form type: 4
Date filed: 5/28/2021, 04:00 PM
Next filing: Jun 7, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GLTO	Stock Option (right to buy)	Award	$0	+18K		$0.00	18K	May 26, 2021	Common Stock	18K	$4.93	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on May 26, 2021, the date of the Issuer's 2021 Annual Meeting of Stockholder, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date. Pursuant to an agreement with OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Advisors Israel II Limited, and OrbiMed Israel GP II, L.P., the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Advisors Israel II Limited, and OrbiMed Israel GP II, L.P., which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VII, L.P. and OrbiMed Israel Partners II, L.P.

Content

Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on May 26, 2021, the date of the Issuer's 2021 Annual Meeting of Stockholder, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date. Pursuant to an agreement with OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Advisors Israel II Limited, and OrbiMed Israel GP II, L.P., the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Advisors Israel II Limited, and OrbiMed Israel GP II, L.P., which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VII, L.P. and OrbiMed Israel Partners II, L.P.